The link between KMT2D and glycolysis may be relevant and worth to explore in detail in lymphoma, as glycolysis measured by expression of aldolase A and GAPDH was associated with significantly shorter transformation-free survival in FL patients (Monrad et al., 2020). This evidence concerns the gene KMT2D and lymphoma.